Financial Anika Therapeutics Delivers Solid Second Quarter 2015 Financial Results and Continued Pipeline Progress byJosh SandbergJuly 30, 2015
Extremities Hospitals Anika Therapeutics Files Investigational Device Exemption to Initiate Phase III Study to Expand Indication of MONOVISC® to Treat Pain Caused by Osteoarthritis of the Hip byJosh SandbergJune 23, 2015
Financial Anika Therapeutics Announces Date of First-Quarter 2015 Financial Results Conference Call byJosh SandbergApril 17, 2015
